In vitro activity of BMY-28100 against common isolates from pediatric infections
- 1 April 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (4) , 630-631
- https://doi.org/10.1128/aac.31.4.630
Abstract
The antibacterial activity of BMY-28100, a new oral cephalosporin, was measured against 300 bacterial isolates from pediatric infections by standard agar dilution methodology. The effect of inoculum size on activity was also assessed. BMY-28100 was more active than cephalexin or cefaclor against all bacterial species tested.This publication has 2 references indexed in Scilit:
- In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputumAntimicrobial Agents and Chemotherapy, 1985
- Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including ‘tolerant’ micro-organismsJournal of Antimicrobial Chemotherapy, 1982